September 2024
1. DAUNGSUPAWONG H, Wiwanitkit V
   Nirmatrelvir/Ritonavir Compared With Placebo/Ritonavir for Long COVID: A Comment.
   Am J Med. 2024;137:e173.
   

   >> Share

   
   May 2024
2. KRUMHOLZ HM, Sawano M, Bhattacharjee B, Caraballo C, et al
   The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVID.
   Am J Med. 2024 May 10:S0002-9343(24)00271-7. doi: 10.1016/j.amjmed.2024.
   

   >> Share

   
   April 2023
3. MILJKOVIC MD, Prasad V
   Paxlovid: A Regulatory Gamble.
   Am J Med. 2023;136:336-338.
   

   >> Share

   
   March 2023
4. AL-OBAIDI MM, Gungor AB, Murugapandian S, Thajudeen B, et al
   The Impact of Nirmatrelvir-Ritonavir in Reducing Hospitalizations Among High-Risk Patients with SARS-Cov-2 During the Omicron Predominant Era.
   Am J Med. 2023 Mar 8:S0002-9343(23)00145-6. doi: 10.1016/j.amjmed.2023.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share